Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR August 2006NPS RADAR August 2006
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR August 2006 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Change of perindopril (Coversyl) salt from erbumine to arginine Professional publication - NPS RADAR - Brief item | The PBAC has approved the change of perindopril salt from erbumine to arginine, based on bioequivalence of the two formulations. Table of therapeutically equivalent doses included. |
| New vaccine for pertussis, diphtheria and tetanus (Adacel) Professional publication - NPS RADAR - Brief item | Pertussis vaccine acellular with diphtheria and tetanus toxoids (Adacel) has been approved by the PBAC for use under the National Immunisation Program (NIP). |
| Medicines listed on the PBS for Indigenous Australians Professional publication - NPS RADAR - Brief item | Thiamine tablets and several topical antifungal preparations were listed on the PBS as authority-required benefits for Aboriginal or Torres Strait Islanders. |
| New drugs added to palliative care list Professional publication - NPS RADAR - Brief item | Lists new drugs included in the Palliative Care section of the PBS, including benzydamine hydrochloride, lactulose mixture, naproxen, and morphine sulfate formulations. |
| Ferrous fumarate 310 mg with folic acid 300 microgram (Ferro-F-Tab) tablets — unrestricted listing Professional publication - NPS RADAR - Brief item | Ferrous fumarate 310 mg with folic acid 300 mg (Ferro-F-Tab) tablets was listed on the PBS after the deletion of FGF (ferrous sulfate 250 mg with folic acid 300 micrograms). |
| Pseudoephedrine on prescription Professional publication - NPS RADAR - Brief item | Pack sizes containing pseudoephedrine 800 mg in liquid form or 720 mg in solid form are now prescription-only, a change designed to mitigate diversion of pseudoephedrine to the synthesis of methamphetamine. |
| Pioglitazone (Actos) and rosiglitazone (Avandia) authority wording changed Professional publication - NPS RADAR - Brief item | The wording of the PBS requirements for pioglitazone (Actos) and rosiglitazone (Avandia) changed on 1 August 2006. The changes are intended to simplify the listings, and there are no changes to the authority requirements. |
| Adrenaline autoinjector (EpiPen) for acute allergic anaphylaxis Professional publication - NPS RADAR - Review | Reviews change to PBS listing allowing immediate prescription of adrenaline autoinjectors after hospital treatment for acute allergic anaphylaxis, and describes management plans and patient education. |
| Fentanyl patches (Durogesic) for chronic pain Professional publication - NPS RADAR - Review | Reviews use of fentanyl patches for chronic pain, including patient selection and education, safety profile, and general analgesia guidelines. |
| Lumiracoxib (Prexige) for osteoarthritis Professional publication - NPS RADAR - Review | Reports urgent withdrawal of lumiracoxib by TGA because of serious liver adverse effects and includes review of lumiracoxib use for osteoarthritis. |
| Moxonidine (Physiotens) for hypertension Professional publication - NPS RADAR - Review | Reviews use of moxonidine for hypertension, including combination drug therapy, safety profile, and dosage guidelines. |
| Correspondence from Janssen-Cilag on fentanyl patches Professional publication - NPS RADAR - Correspondence | Janssen-Cilag would like to bring to the attention of prescribers that the PBAC recommendation permits the use of Durogesic patches to treat opioid-tolerant patients with chronic pain when considered necessary and appropriate by the clinician. |
| Alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) for osteoporosis Professional publication - NPS RADAR - Review | This new formulation of alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) contains twice the cholecalciferol dose of the previous formulation — 5600 units in a once-weekly dose, equivalent to 800 units/day. The cholecalciferol 2800 unit formulation is gradually being phased out by the manufacturer. |
| Alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) — Vitamin D deficiency and supplementation Professional publication - NPS RADAR - Web only item | Describes risk factors for vitamin D deficiency in osteoporosis, sources of vitamin D and daily requirements. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2006-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
